Cite
HARVARD Citation
Shaheen, N. et al. (2015). Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy. Alimentary pharmacology & therapeutics. 41 (7), pp. 649-661. [Online].